Predicting Microvascular Invasion in Hepatocellular Carcinoma Using CT-based Radiomics Model

Tian-Yi Xia1, Zheng-Hao Zhou1, Xiang-Pan Meng1

  • 1From the Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, 87 Ding Jia Qiao Road, Nanjing, China 210009 (T.Y.X., X.P.M., J.H.Z., Q.Y., W.L.W., Y.C.W., T.Y.T., S.H.J.); Institute for AI in Medicine, School of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing, China (Z.H.Z., J.X.); MR Scientific Marketing, Siemens Healthineers, Shanghai, China (Y.S.); Department of Radiology, The Third Affiliated Hospital of Nantong University, Nantong, China (T.Z.); Department of Radiology, The Xiangya Hospital of Central South University, Changsha, China (X.Y.L.); Department of Radiology, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China (Y.L.); and Department of Radiology, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China (W.B.X.).

Radiology
|April 25, 2023
PubMed
Summary

A new hybrid radiomics model accurately predicts microvascular invasion (MVI) in hepatocellular carcinoma (HCC) using CT scans. This model also helps predict patient survival and identifies MVI-related genes involved in glucose metabolism.

Related Concept Videos